Trial Profile
Post-marketing clinical study on milnacipran hydrochloride
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Asahi Kasei Pharma Corp
- 10 Jun 2016 New trial record